Processa Pharmaceuticals, Inc. · NASDAQ:PCSA
Ng George K bought 2,136 Processa Pharmaceuticals, Inc. shares (Form 4/A)
Traded Mar 31, 2026 · Filed Apr 30, 2026
On Mar 31, 2026, Ng George K (Director, Chief Executive Officer) bought 2,136 Processa Pharmaceuticals, Inc. shares at US$2.54 for US$5,425, leaving 2,136 shares. Filed Apr 30, 2026 (Form 4/A).
- Bought
- 2,136 shares
- Price
- US$2.54
- Value
- US$5,425
- Holding after
- 2,136 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Buy | 2,136 | US$2.54 | 2,136 | Direct |
Source
Related
- Processa Pharmaceuticals, Inc.
- Ng George K
- Processa Pharmaceuticals, Inc. shareholders
- Form 4 · Ng George K · Aug 11, 2026
- Form 4 · Ng George K · Jul 1, 2026
- Form 4 · Ng George K · Jun 16, 2026
- Form 4 · Ng George K · Jun 1, 2026
- Form 4 · Ng George K · May 19, 2026
- Schedule 13G · Soleus Capital Master Fund, L.P. · Aug 18, 2026
- Form 4 · Guy Wendy · Jul 1, 2026
- Form 4 · Lin Patrick · Jul 1, 2026
- Form 4 · Skibsted Russell · Jul 1, 2026
- Form 4 · Young David · Jul 1, 2026